<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Since its discovery as a src kinase substrate more than three decades ago, appreciation for the physiologic functions of annexin A2 and its associated proteins has increased dramatically </plain></SENT>
<SENT sid="1" pm="."><plain>With its binding partner S100A10 (p11), A2 forms a cell surface complex that regulates generation of the primary fibrinolytic protease, plasmin, and is dynamically regulated in settings of hemostasis and <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, the complex is transcriptionally upregulated in <z:mp ids='MP_0005039'>hypoxia</z:mp> and promotes pathologic neoangiogenesis in the tissues such as the retina </plain></SENT>
<SENT sid="3" pm="."><plain>Dysregulation of both A2 and p11 has been reported in examples of rodent and human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Intracellularly, A2 plays a critical role in endosomal repair in postarthroplastic <z:hpo ids='HP_0002797'>osteolysis</z:hpo>, and intracellular p11 regulates <z:chebi fb="19" ids="28790">serotonin</z:chebi> receptor activity in psychiatric <z:e sem="disease" ids="C0525045" disease_type="Mental or Behavioral Dysfunction" abbrv="">mood disorders</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>In human studies, the A2 system contributes to the <z:hpo ids='HP_0003256'>coagulopathy</z:hpo> of <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo>, and is a target of high-titer autoantibodies in patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo>, and possibly <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Polymorphisms in the human ANXA2 gene have been associated with <z:hpo ids='HP_0001297'>stroke</z:hpo> and avascular <z:hpo ids='HP_0010885'>osteonecrosis</z:hpo> of bone, two severe complications of <z:e sem="disease" ids="C0002895" disease_type="Disease or Syndrome" abbrv="">sickle cell disease</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Together, these new findings suggest that manipulation of the annexin A2/S100A10 system may offer promising new avenues for treatment of a spectrum of human disorders </plain></SENT>
</text></document>